Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Gujarat Fluorochemicals Limited (FLUOROCHEM.NS)
Noida, IN
Gujarat Fluorochemicals Limited (GFL) is an Indian enterprise involved in the production and distribution of a diverse range of chemical products. Its extensive portfolio includes refrigerant gases, caustic soda, chloromethane, and an array of fluorochemicals such as polytetrafluoroethylene (PTFE), fluoropolymers, fluoromonomers, and specialized fluorointermediates. GFL also supplies various specialty chemicals and engages in associated activities. Among its specific chemical offerings are carbon tetrachloride, chlorine, methylene dichloride, hydrochloric acid, sodium hydrogen sulphate, hydrogen gas, fluorspar, and chloroform. These products are marketed globally under well-known brands like Inoflon, Fluonox, Inoflar, Inolub, and Refron. The company boasts a significant international footprint, exporting its goods to approximately 75 nations across regions including India, Europe, and the United States. Founded in 1987 and based in Noida, India, GFL operated as Inox Fluorochemicals Limited until its renaming in July 2019. It functions as a subsidiary of Inox Leasing and Finance Limited.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.70% | -4.36% | +8.09% | +5.71% | +5.89% | +0.43% | -7.68% | +10.05% | +341.66% | +415.70% | +415.70% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 4 | +1 |
| Buy | 5 | 0 |
| Hold | 3 | 0 |
| Sell | 1 | 0 |
| Strong Sell | 4 | +2 |
-
Revenue growth Chemicals - Specialty: +4.7%+5.5% ★ Q1'26: +11.7% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+5.1% Q1'26: -43.0% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+9.3% ★ Q1'26: +11.0% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+18.9% ★ Q1'26: +15.6% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+7.2% ★ Q1'26: +5.8% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.7% Q1'26: +2.8% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×1.75× Q1'26: 1.85× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 11 Rev. Ana. 10 EPS Ana. |
Mar 2027 12 Rev. Ana. 11 EPS Ana. |
Mar 2028 12 Rev. Ana. 11 EPS Ana. |
Mar 2029 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
26.06B
est: 25.28B (+3.1%)
|
26.50B
est: 25.20B (+5.2%)
|
39.54B
est: 39.64B (-0.3%)
|
56.85B
est: 56.88B (-0.1%)
|
42.81B
est: 42.47B (+0.8%)
|
47.37B
est: 48.64B (-2.6%)
|
49.09B
44.03B – 51.07B
+0.9% YoY
|
63.53B
59.55B – 81.87B
+29.4% YoY
|
77.04B
66.55B – 96.41B
+21.3% YoY
|
97.18B
87.15B – 123.23B
+26.1% YoY
|
| EBITDA |
5.16B
est: 6.60B (-21.8%)
|
5.95B
est: 6.85B (-13.1%)
|
11.73B
est: 10.78B (+8.9%)
|
19.62B
est: 15.46B (+26.9%)
|
8.95B
est: 11.09B (-19.3%)
|
10.91B
est: 11.84B (-7.9%)
|
12.82B
11.50B – 13.34B
+8.2% YoY
|
16.59B
15.55B – 21.38B
+29.4% YoY
|
20.12B
17.38B – 25.18B
+21.3% YoY
|
25.38B
22.76B – 32.18B
+26.1% YoY
|
| EBIT |
3.28B
est: 5.05B (-35.0%)
|
3.96B
est: 5.24B (-24.4%)
|
9.70B
est: 7.57B (+28.2%)
|
17.29B
est: 11.84B (+46.1%)
|
6.14B
est: 8.49B (-27.7%)
|
7.44B
est: 9.85B (-24.5%)
|
9.81B
8.80B – 10.21B
-0.4% YoY
|
12.70B
11.90B – 16.36B
+29.4% YoY
|
15.40B
13.30B – 19.27B
+21.3% YoY
|
19.42B
17.42B – 24.63B
+26.1% YoY
|
| Net Income |
1.96B
est: 2.30B (-14.5%)
|
-2.19B
est: 665.29M (-428.7%)
|
7.87B
est: 8.70B (-9.6%)
|
13.29B
est: 14.43B (-7.9%)
|
4.35B
est: 3.42B (+27.2%)
|
5.46B
est: 6.22B (-12.2%)
|
6.46B
5.47B – 8.52B
+3.9% YoY
|
9.27B
7.48B – 11.32B
+43.5% YoY
|
12.22B
10.57B – 14.91B
+31.8% YoY
|
13.58B
11.79B – 18.37B
+11.2% YoY
|
| SGA |
2.23B
est: 2.11B (+5.7%)
|
2.36B
est: 3.20B (-26.2%)
|
2.88B
est: 3.71B (-22.4%)
|
3.66B
est: 4.52B (-19.2%)
|
3.92B
est: 3.55B (+10.4%)
|
4.74B
est: 4.12B (+15.1%)
|
4.10B
3.68B – 4.27B
-0.4% YoY
|
5.31B
4.98B – 6.84B
+29.4% YoY
|
6.44B
5.56B – 8.06B
+21.3% YoY
|
8.12B
7.28B – 10.30B
+26.1% YoY
|
| EPS |
17.87
est: 20.90 (-14.5%)
|
-19.91
est: 5.75 (-446.3%)
|
71.66
est: 75.23 (-4.7%)
|
120.97
est: 124.73 (-3.0%)
|
39.59
est: 31.11 (+27.3%)
|
49.71
est: 49.04 (+1.4%)
|
57.52
49.80 – 77.56
+17.3% YoY
|
78.63
68.09 – 103.03
+36.7% YoY
|
102.55
96.19 – 135.71
+30.4% YoY
|
124.00
107.37 – 167.22
+20.9% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-27 | B- | 2/5 | 1/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-26 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-25 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Vanguard Emerging Markets Ex-China ETF VEXC | 0.02% | 40.7K | 0.07% |
| 2 | Schwab Emerging Markets Equity ETF SCHE | 0.01% | 1.75M | 0.06% |
| 3 | Vanguard FTSE Emerging Markets UCITS ETF (USD) Distributing VDEM.L | 0.01% | 739.3K | 0.17% |
| 4 | Vanguard FTSE Emerging Markets UCITS ETF (USD) Accumulating VFEA.L | 0.01% | 739.3K | 0.17% |
| 5 | Vanguard FTSE Asia ex Japan Shares Index ETF VAE.AX | 0.01% | 72.8K | 0.40% |
| 6 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.01% | 363.0K | 0.26% |
| 7 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.01% | 160.9K | 0.48% |
| 8 | Vanguard FTSE Emerging Markets ETF VWO | 0.01% | 17.91M | 0.06% |
| 9 | Vanguard ESG International Stock ETF VSGX | 0.00% | 245.6K | 0.10% |
| 10 | Vanguard All-World ex-US Shares Index ETF VEU.AX | 0.00% | 146.4K | 0.04% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Vivek Kumar Jain | MD & Non-Independent Director | 150M | male |
| Bir Kapoor | Deputy MD & NonIndependent Director | 57M | male |
| Bhavin V. Desai | Company Secretary & Compliance Officer | — | male |
| Govind Vijay | Head of Legal & Contracts | — | male |
| Akhil Jindal | Group Chief Financial Officer | — | male |
| Manoj Agrawal | Chief Financial Officer | — | male |
| Saurabh Gupta | Group Chief Digital & Information officer | — | male |
| Vitthal Genbhau Gund | Chief Technology Officer & President-R&D | — | male |
| Kallol Chakraborty | Head of Group Corporate Human Resources | — | male |
| Anil Killarikar | Chief Operations Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for FLUOROCHEM.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
